Price T Rowe Associates Inc Natera, Inc. Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Natera, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 12,187,816 shares of NTRA stock, worth $1.95 Billion. This represents 0.23% of its overall portfolio holdings.
Number of Shares
12,187,816
Previous 10,537,743
15.66%
Holding current value
$1.95 Billion
Previous $1.49 Billion
38.18%
% of portfolio
0.23%
Previous 0.18%
Shares
19 transactions
Others Institutions Holding NTRA
# of Institutions
688Shares Held
129MCall Options Held
669KPut Options Held
1.11M-
Vanguard Group Inc Valley Forge, PA12.7MShares$2.03 Billion0.04% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.18 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.08 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.82MShares$771 Million3.66% of portfolio
-
Stanley Druckenmiller Duquesne Family Office LLC | New York, Ny3.4MShares$544 Million15.72% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $15.5B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...